Location History:
- Dusseldorf, DE (1976)
- Kaarst, DE (1976 - 1978)
Company Filing History:
4 out of 833,002 Years Active: 1976-1978
Title: The Innovations of Karl Credner
Introduction
Karl Credner is a notable inventor based in Kaarst, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypolipidaemic agents. With a total of 4 patents to his name, Credner's work has had a meaningful impact on medical science.
Latest Patents
Credner's latest patents include innovative compounds such as the Theophylline salts of 5-methylisoxazole-3-carboxylic acid. These salts, which include N-unsubstituted, N-monosubstituted, and N,N-disubstituted 7-(3-amino-2-hydroxypropyl)theophylline, are recognized for their hypolipidaemic properties. Another significant patent involves esters of ophyllinylacetic acid, which are useful for their effects on serum lipoids and for treating adverse hyperlipidemic states in humans.
Career Highlights
Throughout his career, Credner has focused on the synthesis of compounds that can improve health outcomes. His innovative approach to pharmaceutical chemistry has led to the development of new treatments that address critical health issues related to lipid levels in the body.
Collaborations
Credner has worked alongside esteemed colleagues such as Manfred Tauscher and Gunter Brenner. Their collaborative efforts have contributed to the advancement of research in the pharmaceutical field.
Conclusion
Karl Credner's contributions to the field of pharmaceuticals through his patents and collaborative work highlight his role as an influential inventor. His innovative compounds continue to pave the way for advancements in medical treatments.